Related references
Note: Only part of the references are listed.Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia
Anna Candoni et al.
CLINICAL TRANSPLANTATION (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia
Giacomo Gianfaldoni et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Wilms' tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome
Antonia Busse et al.
ANNALS OF HEMATOLOGY (2009)
High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival
David A. Jacobsohn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia
Anna Candoni et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
WT1 monitoring in core binding factor AML: Comparison with specific chimeric products
Adriana Lasa et al.
LEUKEMIA RESEARCH (2009)
Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease
YaZhen Qin et al.
LEUKEMIA RESEARCH (2009)
Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia
Mauri M. Haemaelaeinen et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response
Y. Z. Qin et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2008)
Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia
Xiao-Jun Huang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia
H Lapillonne et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
WT1 gene transcript assay for relapse in acute leukemia after transplantation
H Ogawa et al.
LEUKEMIA & LYMPHOMA (2004)
Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation
M Uzunel et al.
BONE MARROW TRANSPLANTATION (2004)
Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program
E Beillard et al.
LEUKEMIA (2003)
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program
J Gabert et al.
LEUKEMIA (2003)
Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan
S Imashuku et al.
BONE MARROW TRANSPLANTATION (2003)
The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia
H Ogawa et al.
BLOOD (2003)
Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1)
H Tamaki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Share Paper
